Helicobacter pylori 1990: Proceedings of the Second International Symposium on Helicobacter pylori Bad Nauheim, August 25–26th, 1989

Front Matter....Pages I-XIII
Front Matter....Pages 1-1
Urease and Catalase as Virulence Factors of Helicobacter pylori ....Pages 3-12
Discussion....Pages 13-14
Adhesion Properties of Helicobacter pylori ....Pages 15-18
 Helicobacter pylori Hemagglutinins....Pages 19-27
Discussion....Pages 28-29
Cytotoxic Activity of Helicobacter pylori ....Pages 30-34
Discussion....Pages 35-36
 Helicobacter pylori and Gastric Mucus Integrity....Pages 37-47
Discussion....Pages 48-51
 Helicobacter pylori and Other Gastric Spirilla: Similarities and Differences....Pages 52-62
Further Observations on Human Spirobacteria....Pages 63-70
Discussion....Pages 71-73
Animal Models of Helicobacter pylori Gastritis....Pages 74-80
Discussion....Pages 81-82
Isotype and Specificity of Local and Systemic Anti -Helicobacter pylori Antibodies....Pages 83-87
Discussion....Pages 88-88
Front Matter....Pages 89-89
Survival of Helicobacter pylori in the Aquatic Environment....Pages 91-94
Discussion....Pages 95-96
 Helicobacter pylori in Human Populations: The Present and Predictions of the Future Based on the Epidemiology of Polio....Pages 97-102
Discussion....Pages 103-103
Front Matter....Pages 89-89
Transmission and Sources of Helicobacter pylori....Pages 104-109
Discussion....Pages 110-112
Chronic Gastritis: Epidemiology and Relationship to Peptic Ulcer Diseases....Pages 113-119
Gastritis Epidemiology and Natural History....Pages 120-128
Discussion....Pages 129-131
Epidemiology of Gastric Metaplasia....Pages 132-138
Discussion....Pages 139-139
Epidemiology of Duodenal Ulcer Disease....Pages 140-145
Discussion....Pages 146-146
Front Matter....Pages 147-147
In Vitro Sensitivity of Helicobacter pylori ....Pages 149-153
Discussion....Pages 154-156
Antibiotic Concentrations in Gastric Mucosa: The Guinea Pig Model....Pages 157-161
Discussion....Pages 162-162
Acquired Resistance to Antibiotics: An Underestimated Cause of Failure in the Treatment of Helicobacter pylori Infection....Pages 163-170
Discussion....Pages 171-174
Clinical Pharmacology of Bismuth — Studies from the Royal Free Hospital....Pages 175-182
The Absorption of Bismuth from Orally Administered Tripotassium Dicitrato Bismuthate and Bismuth Subsalicylate....Pages 183-187
Pharmacokinetics of Bismuth Compounds in Patients with Gastritis and Ulcer Disease During Standard Treatment....Pages 188-190
Discussion....Pages 191-195
Pharmacology and Safety of Bismuth Compounds....Pages 196-201
Front Matter....Pages 147-147
Discussion....Pages 202-205
Front Matter....Pages 207-207
Treatment Regimens to Eradicate Helicobacter pylori ....Pages 209-215
Discussion....Pages 216-217
Effect of Eradication of Helicobacter pylori on Nonulcer Dyspepsia Syndrome and Chronic Gastritis....Pages 218-225
Discussion....Pages 226-228
Front Matter....Pages 229-229
Histological Definition and Scoring of Gastritis....Pages 231-237
Discussion....Pages 238-241
Measuring Symptoms in Helicobacter pylori -Associated Gastritis and Non-Ulcer Dyspepsia....Pages 242-247
Discussion....Pages 248-251
Optimal Study Design for Therapeutic Trials in Helicobacter pylori- Associated Nonulcer Dyspepsia....Pages 252-259
Discussion....Pages 260-261
Optimal Design for Peptic Ulcer Studies....Pages 262-267
Discussion....Pages 268-270